drugset / Trial / NCT03009799
Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
RandomizedParallel-groupDouble-blindTreatment
Summary
This clinical investigation aims at demonstrating that NCX-4240 is effective and safe in decreasing the number of days where adenoviral conjunctivis is detected in the eye and in reducing the duration and/or the severity of the signs and symptoms of adenoviral conjunctivis
Timeline
- Start
- 2017-01
- Primary completion
- 2017-08
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Iota-Carrageenan | Other / unclassified | 3.2 mg/ml | Other |